Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 2
2002 5
2003 1
2004 2
2005 2
2006 3
2007 1
2008 3
2009 5
2010 1
2011 2
2012 3
2013 5
2014 5
2015 1
2016 5
2017 8
2018 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. JAMA. 2002 Dec 18;288(23):2981-97. doi: 10.1001/jama.288.23.2981. JAMA. 2002. PMID: 12479763 Clinical Trial.
Chlorthalidone versus hydrochlorothiazide.
Einhorn PT, Cushman WC, Whelton PK; ALLHAT Collaborative Research Group. Einhorn PT, et al. Ann Intern Med. 2013 Jun 18;158(12):922-3. doi: 10.7326/0003-4819-158-12-201306180-00018. Ann Intern Med. 2013. PMID: 23778917 No abstract available.
ALLHAT: setting the record straight.
Davis BR, Furberg CD, Wright JT Jr, Cutler JA, Whelton P; ALLHAT Collaborative Research Group. Davis BR, et al. Ann Intern Med. 2004 Jul 6;141(1):39-46. doi: 10.7326/0003-4819-141-1-200407060-00013. Ann Intern Med. 2004. PMID: 15238369 Review.
Treatment-Resistant Hypertension and Outcomes Based on Randomized Treatment Group in ALLHAT.
Bangalore S, Davis BR, Cushman WC, Pressel SL, Muntner PM, Calhoun DA, Kostis JB, Whelton PK, Probstfield JL, Rahman M, Black HR; ALLHAT Collaborative Research Group. Bangalore S, et al. Am J Med. 2017 Apr;130(4):439-448.e9. doi: 10.1016/j.amjmed.2016.10.002. Epub 2016 Oct 27. Am J Med. 2017. PMID: 27984005 Free PMC article. Clinical Trial.
Risk Factors Influencing Outcomes of Atrial Fibrillation in ALLHAT.
Haywood LJ, Davis BR, Piller LB, Simpson LM, Ghosh A, Einhorn PT, Ford CE, Probstfield JL, Soliman EZ, Wright JT Jr; ALLHAT Collaborative Research Group. Haywood LJ, et al. J Natl Med Assoc. 2018 Aug;110(4):343-351. doi: 10.1016/j.jnma.2017.07.003. Epub 2017 Jul 24. J Natl Med Assoc. 2018. PMID: 30126559 Free PMC article. Clinical Trial.
Impact of the ALLHAT/JNC7 Dissemination Project on thiazide-type diuretic use.
Stafford RS, Bartholomew LK, Cushman WC, Cutler JA, Davis BR, Dawson G, Einhorn PT, Furberg CD, Piller LB, Pressel SL, Whelton PK; ALLHAT Collaborative Research Group. Stafford RS, et al. Arch Intern Med. 2010 May 24;170(10):851-8. doi: 10.1001/archinternmed.2010.130. Arch Intern Med. 2010. PMID: 20498411 Free PMC article.
52 results